Financials
PDS Biotech: 2nd Quarter Results, Business Update | 14-Aug-2023 | 17:55 | RNS |
PDS Biotech: Submission of Phase 3 Protocol to FDA | 14-Aug-2023 | 17:51 | RNS |
Grant of Options, Issue of Shares, Director/PDMR | 03-Jul-2023 | 07:00 | RNS |
DName-iT Holdings Limited Fundraising | 30-Jun-2023 | 07:00 | RNS |
Result of AGM & Board Changes | 29-Jun-2023 | 11:04 | RNS |
Vortex Fundraising | 22-Jun-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 07-Jun-2023 | 07:00 | RNS |
Notice of AGM | 06-Jun-2023 | 07:00 | RNS |
Preliminary Results for the year ended 31 Dec 2022 | 31-May-2023 | 07:01 | RNS |
Board Changes | 31-May-2023 | 07:00 | RNS |
PDS Business Update and First Quarter Results | 15-May-2023 | 15:16 | RNS |
Glycotest, Inc. Fundraising | 02-May-2023 | 07:00 | RNS |
Business Update | 03-Apr-2023 | 07:00 | RNS |
PDS Update | 30-Mar-2023 | 15:51 | RNS |
PDS Business Update and 2022 Financial Results | 28-Mar-2023 | 15:50 | RNS |
Currency | UK Pounds |
Share Price | 64.30p |
Change Today | 1.30p |
% Change | 2.07 % |
52 Week High | 76.50 |
52 Week Low | 49.00 |
Volume | 3,071 |
Shares Issued | 23.95m |
Market Cap | £15.40m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:52 | 446 @ 61.41p |
08:00 | 2,625 @ 61.41p |
CEO | Ilian Iliev |
CFO | Stephen Crowe |
You are here: research